Hogan Lovells advises Frimex on its acquisition of Gulf Neo Trading Company
Hogan Lovells has advised Frimex International Investment Company on its acquisition of a majority stake in Gulf Neo Trading Company, one of the GCC’s largest distributors of pharmaceutical and medical devices.
The Hogan Lovells team advised Frimex, a family-owned investment firm with more than 46 years of experience and a long-standing presence in the Kingdom of Saudi Arabia, whose diverse portfolio spans the GCC and global markets, on this strategic investment. Gulf Neo is a leading distributor of pharmaceutical and medical devices in the GCC, recognized for its high-quality standards and specialised portfolio.
Guided by the values of its parent company, HSA Group, Frimex continues to pursue transformative opportunities that uplift communities and economies, driving innovation, integrity, and responsible stewardship across all its ventures. This transaction marks a significant milestone for the firm, reinforcing its commitment to sustainable growth across the healthcare sector. Partnering with Gulf Neo will enable Frimex to further enhance access to high-quality medical and pharmaceutical products throughout the region, supporting the advancement of healthcare standards.
Walid Salib commented, “This transaction underscores our commitment to supporting clients as they pursue strategic, high‑impact investments in the Kingdom. We are pleased to have advised Frimex on a deal that strengthens its position in a sector so vital to the region’s future.”
The Hogan Lovells Riyadh team was led by Partner Walid Salib, supported by associates Hana Wafa, Mohamed Alshaikh, Ghaida Albuainain and Ahmad Alshaikh.
